Clinical TrialsSearch results
Number of results: 564
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2005-09-12
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid Leukemia
- Acute myeloid Leukemia Myelodysplastic syndrome
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2008-01-22
Recruiting
- A study to learn more about asundexian (also called BAY2433334) for prevention of ischemic stroke in male and female participants aged 18 years and older who already had such a stroke due to a blood clot that formed outside the heart and travelled to the brain, or temporary stroke-like symptoms
- Acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
- Masashi Myoishi
- 2023-02-01
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)
- Acute promyelocytic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2007-03-19
Other
- Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study
- acute promyelocytic leukemia
- Japan Adult Leukemia Study Group (JALSG)
- 2005-09-13
Other
- Multicenter study of a randomized controlled trial with or without maintenance/intensification therapy in patients with previously untreated acute promyelocytic leukemia (JALSG APL97 study)
- acute promyelocytic leukemia (APL)
- Japan Adult Leukemia Study Group
- 2005-09-14
Recruiting
- Phase I/II study of KA-301 for acute spinal cord injury
- acute spinal cord injury
- Maeda Takeshi
- 2023-08-08
Completed
- Post remission therapy including arsenic trioxide against acute promylocytic leukemia (APL) in elderly patients. (JALSG APL212G study)
- Adult acute promylocytic leukemia
- Takeshita Akihiro
- 2019-03-14
Completed
- Post remission therapy with arsenic trioxide and gemtuzumab ozogamicin in acute promylocytic leukemia (JALSG APL212)
- Adult acute promylocytic leukemia
- Takeshita Akihiro
- 2019-03-14
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17